Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$43.76 - $53.11 $1.7 Million - $2.06 Million
-38,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$41.69 - $54.95 $149,875 - $197,545
-3,595 Reduced 8.48%
38,800 $1.91 Million
Q4 2020

Feb 02, 2021

SELL
$41.16 - $47.47 $32,928 - $37,976
-800 Reduced 1.85%
42,395 $1.79 Million
Q3 2020

Nov 05, 2020

BUY
$43.36 - $53.53 $47,696 - $58,883
1,100 Added 2.61%
43,195 $1.98 Million
Q2 2020

Aug 12, 2020

BUY
$46.37 - $57.58 $149,265 - $185,350
3,219 Added 8.28%
42,095 $2.11 Million
Q1 2020

May 12, 2020

SELL
$40.22 - $62.0 $1.48 Million - $2.28 Million
-36,716 Reduced 48.57%
38,876 $2 Million
Q4 2019

Jan 27, 2020

BUY
$57.95 - $66.61 $2.32 Million - $2.67 Million
40,016 Added 112.48%
75,592 $4.67 Million
Q3 2019

Oct 31, 2019

BUY
$60.08 - $88.17 $685,632 - $1.01 Million
11,412 Added 47.23%
35,576 $2.14 Million
Q2 2019

Aug 15, 2019

SELL
$81.3 - $97.35 $845,926 - $1.01 Million
-10,405 Reduced 30.1%
24,164 $2.04 Million
Q1 2019

May 03, 2019

SELL
$69.08 - $105.66 $27,632 - $42,264
-400 Reduced 1.14%
34,569 $3.3 Million
Q4 2018

Feb 08, 2019

SELL
$65.41 - $84.65 $264,779 - $342,663
-4,048 Reduced 10.37%
34,969 $2.48 Million
Q3 2018

Nov 13, 2018

BUY
$85.46 - $126.37 $670,348 - $991,246
7,844 Added 25.16%
39,017 $3.33 Million
Q2 2018

Aug 15, 2018

SELL
$81.85 - $120.51 $769,635 - $1.13 Million
-9,403 Reduced 23.17%
31,173 $3.61 Million
Q1 2018

May 11, 2018

BUY
$57.91 - $92.15 $2.35 Million - $3.74 Million
40,576 New
40,576 $3.28 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $103M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.